Lupin launches Varenicline Tablets in the US
It is indicated for use as an aid to smoking cessation treatment
Lupin announced the launch of Varenicline Tablets, 0.5 mg and 1 mg, after having received an approval from the United States Food and Drug Administration (US FDA). Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V.
It is indicated for use as an aid to smoking cessation treatment.
Varenicline Tablets (RLD Chantix) had estimated annual sales of $412 million in the US. (IQVIA MAT November 2023).
- Advertisement -